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a  b  s  t  r  a  c  t
Inﬂammatory  bowel  diseases,  which  include  Crohn’s  disease  and  ulcerative  colitis,  are  characterized  by
chronic  and  relapsed  gut inﬂammation.  Caulerpa  mexicana  is  a type  of  green  marine  algae  that  can  be
found in tropical  areas,  such  as  the  Brazilian  Coastland.  These  macrophytes  exhibit  in  vitro  and  in  vivo
anti-inﬂammatory  properties  such  as the  ability  to reduce both  cell migration  to  different  sites  and  edema
formation  induced  by chemical  irritants.  The  aim  of this  study  was  to examine  the  effect  of the C. mexicana
methanolic  extract  on  the  treatment  of colitis  induced  by  dextran  sodium  sulfate.  Acute  experimental
colitis  was induced  in BALB/c  mice  by treatment  with  3%  dextran  sodium  sulfate  orally  for  14 days.  During
this  14-day  period,  C. mexicana  methanolic  extract  (2  mg/kg/day)  was  given  intravenously  on  alternate
days.  Treatment  with  the  methanolic  extract  signiﬁcantly  attenuated  body  weight  loss  and  severe  clinicallcerative colitis
ytokines
issue damage
symptoms.  This  was  associated  with  a remarkable  amelioration  of  colonic  architecture  disruption  and
a signiﬁcant  reduction  in pro-inﬂammatory  cytokine  production.  These  results  suggest  that  the  anti-
inﬂammatory  action  of  C.  mexicana  methanolic  extract on colorectal  sites  may  be a useful  therapeutic
approach  for  inﬂammatory  bowel  diseases.
© 2015 Sociedade  Brasileira  de  Farmacognosia.  Published  by Elsevier  Editora  Ltda.  All  rights  reserved.ntroduction
Inﬂammatory bowel diseases (IBD) including Crohn’s disease
CD) and ulcerative colitis (UC), are characterized by chronic and
elapsed gut inﬂammation. UC is associated with intestinal inﬂam-
ation and often results in weight loss, diarrhea accompanied by
lood and mucus, fever, gastric dysmotility and colon shorten-
ng (Hendrickson et al., 2002; Byrne and Viney, 2006; Cho, 2008).
raditional therapeutic agents, such as 5-aminosalicylates (5-ASA)
nd corticosteroids, are still used to treat IBD. Some immunomod-
lators, such as azathioprine and 6-mercaptopurine, as well as
ntibiotics are becoming important in steroid resistant and steroid-
ependent patients (Cho et al., 2011). Considering the serious
ide effects associated with the conventional treatment, natural
∗ Corresponding author.
E-mail: jtsouto@cb.ufrn.br (J.T. Souto).
http://dx.doi.org/10.1016/j.bjp.2015.10.001
102-695X/© 2015 Sociedade Brasileira de Farmacognosia. Published by Elsevier Editoraproducts, including those from marine origin, have been studied to
aid in the improvement of IBD clinical symptoms (D’Orazio et al.,
2012).
Caulerpa mexicana is a green marine algae, from the Bryop-
sidales Order and the Cauleparceae Family, which can be found
especially in tropical areas such as the Brazilian Coastland (Neto
et al., 2008). These macrophytes have many bioactive compounds,
such as polysaccharides, terpenes and ﬂavonoids, which have dif-
ferent pharmacological activities with antitumor, antiprotozoal,
antiviral, antioxidant, antinoceptive, anti-inﬂammatory and anti-
coagulant effects (Rocha et al., 2007; Souza et al., 2009a,b; Matta
et al., 2011; Torres et al., 2014). Recently, we  showed that aqueous
and methanolic extracts of C. mexicana have in vitro and in vivo
anti-inﬂammatory properties that reduce the pro-inﬂammatory
cytokine levels in macrophage culture supernatants stimulated
with LPS and decrease the cell migration to different sites that
occurs following stimulation with zymosan. The extracts also
reduce edema formation induced by chemical irritants (Bitencourt
et al., 2011).
 Ltda. All rights reserved.
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The oral administration of dextran sulfate sodium salt (DSS)
s widely used as a model for UC. This model is characterized by
ucosal inﬁltration of inﬂammatory cells, epithelial injury and
lceration (Kim et al., 2010). Another study reported that mice with
SS-induced colitis exhibited phenotypic characteristics similar to
uman acute and chronic UC (Okayasu et al., 1990). We  previously
howed that C. mexicana extracts exhibit anti-inﬂammatory activ-
ty (Bitencourt et al., 2011). Therefore, the aim of this study was to
xamine the treatment effects of the C. mexicana methanolic extract
n DSS-induced colitis.
aterials and methods
xtraction and isolation of the methanolic extract of C. mexicana
The green algae Caulerpa mexicana was collected in the coastal
egion of Bessa beach (7◦03′52′′ S/34◦49′51′′ W),  Joao Pessoa, in the
araiba State of Brazil in April 2008. The specimen was  identiﬁed
y Dr. George Emmanuel Cavalcanti de Miranda. Voucher speci-
ens of C. mexicana (JPB 13985) have been deposited in the Lauro
ires Xavier Herbarium at the Federal University of Paraiba, Brazil.
resh algae samples were washed, dried, lyophilized and exhaus-
ively extracted with methanol in a Soxhlet apparatus, to obtain the
ethanolic extract.
nimals
Male BALB/c mice (6–8 weeks old) were used in the experi-
ent. All mice were housed ﬁve per cage at a room temperature
f 22 ± 2 ◦C and under a 12 h:12 h light/dark cycle. They had free
ccess to food and water. Groups of ﬁve animals were used in
ach test group and control animals received saline only. All in vivo
xperiments were approved by “Ethics Committee on Animal Use,
EUA/UFRN,” under protocol number 044/2009, which was  in
ccordance with the guidelines of the Brazilian Committee for Ani-
al  Experimentation (COBEA).
ssessment of DSS-induced colitis
Previously we evaluate the dose-response of C. mexicana
ethanolic extract in peritonitis, ear swelling and air pouch mod-
ls, and the dose that showed better anti-inﬂammatory effect was
 mg/kg, and this is chosen to be used in colitis model (Bitencourt
t al., 2011). Our colitis model was developed following the
ethodology described by Kim et al. (2010) and Melgar et al. (2006)
ith the aim of evaluate colitis during its acute phase. Therefore,
xperimental colitis was induced by giving mice drinking water ad
ibitum containing DSS 3% (w/v) for 14 days. Mice were monitored
arefully every day to conﬁrm that they consumed approximately
qual volumes of DSS-containing water. For the experiment, the
ice were divided into three experimental groups. The ﬁrst group
as kept as vehicle-treated control and treated with saline in the
ame route as the methanolic extract, and the second group was
iven drinking water with DSS only throughout the experimen-
al period. The other group consisted of mice receiving 3% DSS
nd administered methanolic extract (2 mg/kg/day) by intravenous
oute on alternate days for 14 days. The mice treatment with the
ethanolic extract began on the same day that DSS administration
n drinking water.
valuation of disease activity index (DAI)The mice were checked daily for colitis development by mon-
toring body weight, gross rectal bleeding and stool consistency.
he overall disease severity was assessed by a clinical scoring sys-
em on a scale of 0–4. Brieﬂy, the scoring was as follows: 0, noe Farmacognosia 25 (2015) 677–682
weight loss, no occult blood in the stools and normal stool con-
sistency; 1, weight loss of 1–5%, no occult blood and normal stool
consistency; 2, 5–10% weight loss, positive for fecal occult blood
and loose stools; 3, 10–20% weight loss, positive for fecal occult
blood and loose stools; and 4, greater than 20% weight loss, gross
rectal bleeding and diarrhea.
Colon tissue culture
Intestine tissue samples corresponding to the transverse colon
were exhaustively washed with RPMI-1640 medium containing 2%
fetal bovine serum and gentamicin before being cut into smaller
pieces. Then, approximately 0.5 cm of tissue was placed in 1 ml of
10% FBS containing RPMI-1460 medium in 24-well tissue culture
plates and incubated for 24 h at 37 ◦C in 5% CO2. Thereafter, the
supernatants were collected for determination of IL-6, IL-12, TNF-,
IFN- and IL-17 by ELISA.
ELISA for cytokines
The IFN-, IL-17, IL-12, TNF- and IL-6 concentrations in the
cell-free culture supernatants of the colon tissues were measured
in triplicate, utilizing a set enzyme-linked immunosorbent assay
kit (eBioscience, San Diego, CA, USA) according to manufacturer’s
instructions.
Histopathology
After the period of induction of colitis by DSS, animals were
euthanized; fragments of 0.5 cm of ascendant colon were obtained,
ﬁxed in a solution of 4% formalin and used for histological analysis
by conventional tissue preparation methods. Tissue samples were
viewed under the light microscope (40×) after hematoxylin and
eosin (H&E) staining.
Results
Treatment of mice with C. mexicana methanolic extract
decreased the DAI after colitis induction
The parameter used to evaluate the development of the disease
was the DAI, which is associated with observed clinical symptoms
such as weight loss, stool consistency, fecal blood and diarrhea. In
our model the DAI was evaluated individually during the 14 days of
the study. The highest DAI score was  observed in DSS group (Fig. 1D,
closed squares), which exhibited intense weight loss from the 11th
day, as shown in Fig. 1C (closed squares), as well as persistent and
severe diarrhea (Fig. 1A) and fecal blood (Fig. 1B). On the other hand,
the group treated with the methanolic extract had weight devel-
opment similar to the group that received normal water (Fig. 1C,
closed cycles), low disease development rate (Fig. 1D, closed tri-
angles), with no blood in the stool (Fig. 1B, closed triangles) and
little diarrhea (Fig. 1A, closed triangles) compared with the group
receiving DSS. Overall, the DAI score of the C. mexicana’s methano-
lic extract-treated group was  signiﬁcantly lower than that of the
DSS control group from day four following administration of DSS.
The treatment of mice with C. mexicana methanolic extract
ameliorated the tissue damage in the colon after colitis induction
To evaluate the tissue damage after colitis induction in mice,
histological analysis was conducted on colon sections. For the
colon histological analyses, the slides were stained with hema-
toxylin and eosin and then evaluated on the light microscope.
Photomicrographs were subsequently obtained at 40, 100 and
200× magniﬁcations. Fig. 2 shows that the animals receiving
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Fig. 1. The disease activity index (DAI) in mice treated with Caulerpa mexicana methanolic extract in the colitis model. (A) Stool consistency score, (B) bleeding score, (C)
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weight loss score and (D) total DAI score. The mice were administered 3% DSS in
reatment (2 mg/kg/day i.v.  up to 14 days); saline was used as a negative control. 
p  < 0.05 in the vehicle-treated control group vs. the DSS-induced colitis group; sign
ater without DSS presented normal colon structures with crypts
nd other morphological structures preserved (Fig. 2A and B).
n the other hand, colon samples from the mice that received
SS showed typical inﬂammatory changes in the colon architec-
ure and a diffuse inﬂammatory inﬁltrate, composed mainly by
ononuclear cells. At certain points the inﬂammation was more
ntense, promoting small foci of glandular destruction and mod-
rate ulceration, crypt dilation and goblet cell depletion as shown
n Fig. 2C and D. Although they had a slight inﬂammatory reac-
ion decrease, the group treated with the methanolic extract had
n acute inﬂammatory inﬁltrate observed on the entire length
f the mucosa that was  intense in some areas, leading to glan-
ular destruction and ulceration points. In some areas, abscesses
ith exudate were present, although these were less intense and
ore focal when compared with the group that received only DSS
Fig. 2E and F).
he treatment of mice with methanolic extract of C. mexicana
ecreased Th1 and Th17 cytokine production in the colon culture
upernatant
Because cytokines are important mediators of inﬂammation in
olitis models, the next step was to evaluate the Th1 and Th17
ytokine levels in the in vitro colon tissue culture supernatant. The
esults presented in Fig. 3 show an intense production of IFN-
Fig. 3A), IL-6 (Fig. 3B), IL-12 (Fig. 3C), IL-17A (Fig. 3D) and TNF-
Fig. 3E) in the colon culture supernatants of mice that received
SS in their drinking water. However, the mice treated with the
ethanolic extract of C. mexicana exhibited a signiﬁcant decrease in
he levels of these cytokines compared with the group that received
SS in their drinking water.
iscussionUC, which is major form of IBD, is a nonspeciﬁc inﬂammatory
isease of the large intestine. In addition, it is a lifelong illness
ith profound emotional and social impacts, it causes seriousdrinking water (ad libitum) for 14 days with or without methanolic extract (ME)
es in DAI level were evaluated daily throughout the 15-day experimental period.
ces between treated groups were determined by ANOVA.
intestinal tract damage and its progression to chronic UC can lead to
colon cancer (Xavier and Podolsky, 2007; Shanahan and Bernstein,
2009). The UC induced in mice by drinking water containing DSS
leads to clinical symptoms such as weight loss, diarrhea, fecal blood,
mucosal ulceration and colonic shortening (Kim et al., 2010). In this
study, we evaluated the development of the disease for 14 days
(Melgar et al., 2006). The highest DAI score was observed in the DSS
group that developed intense weight loss, fecal bleeding and per-
sistent and severe diarrhea. On the other hand, the animals treated
with the methanolic extract did not show the clinical symptoms of
colitis or weight loss.
Because UC is characterized by an intense inﬂammatory pro-
cess, the ability of the methanolic extract to reduce the colitis
clinical symptoms demonstrates the extract’s anti-inﬂammatory
activity. In addition, the colon histological analysis shows that the
animals that received water with DSS presented typical inﬂamma-
tory changes in their colon architecture that was  slightly attenuated
when the animals were treated with the methanolic extract. These
effects on clinical symptoms and on histological parameters could
be due to the presence of antioxidant compounds, such as -
carotene and -tocopherol that have been isolated from C. mexicana
(Sousa et al., 2008). The inhibition of free radicals by these com-
pounds could be decisive in decreasing the oxidative stress that
causes damage to the intestinal epithelial barrier (Zhu and Li, 2012;
Zheng et al., 2012). Furthermore, we  reported previously that the
C. mexicana methanolic extract inhibits cell migration in a model
of peritonitis (Bitencourt et al., 2011) and we believe that this inhi-
bition could also be happening in the colitis model presented here,
contributing to the attenuation of the clinical symptoms as well
as leading to the slight improvement on the histological analysis
observed by the inﬂammatory inﬁltrate reduction in the colons of
C. mexicana treated animals.
The DSS induced-colitis animal model has a number of
advantages over other models. These advantages include simple
experimental methods, reproducibility of the development time-
course as well as colitis severity among individual mice, and relative
uniformity of the induced lesions. Therefore, this experimental
680 M.A.O. Bitencourt et al. / Revista Brasileira de Farmacognosia 25 (2015) 677–682
Fig. 2. Tissue damage in the colon of mice with DSS-induced colitis treated with methanolic extract of Caulerpa mexicana. Saline was used as a negative control (A and B).
Representative sections of colon tissue from mice that received in their drinking water 3% DSS which were treated with methanolic extract of C. mexicana (2 mg/kg, i.v.,  up
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co  14 days), showing an improvement in inﬂammatory processes and restoration of
xtract  under study (C and D), showing the destruction of the mucosal tissue which 
etermined by H&E staining. Original magniﬁcation in A and F was  100×, in B and D
odel is reliable for studying the pathogenesis of UC and for test-
ng drugs or phytochemicals for treatment (Cunha et al., 2013;
ucero et al., 1996). The literature shows that there is an imbalance
etween pro-inﬂammatory and anti-inﬂammatory cytokines in UC
Papadakis, 2004). Pro-inﬂammatory cytokines are responsible for
etermining the nature of the immune response in UC and can
timulate the rapid synthesis and secretion of inﬂammatory medi-
tors, such as reactive oxygen and nitrogen species, leukotrienes,
latelet activating factor and prostaglandins (Neuman, 2007). The
yperactivation of immune cells is another important factor in IBD
rogression and is associated with high levels of pro-inﬂammatory
ytokines from Th1 and Th17 pattern of immune response, such
s TNF-, IL-6 and IFN-, which are known to be involved in
olon damage (Gálvez, 2014). Cytokines are important mediatorssal tissue (E and F) and colon sections from animals that were not treated with the
en replaced by inﬂammatory granulation tissue (arrow). Histological changes were
 200× and in C and E was 40×.
of inﬂammation and elevated levels of pro-inﬂammatory cytokines
are observed not only in the inﬂamed gut of IBD patients but also in
animals with DSS-induced colitis (Neuman, 2007). Because of this
it is interesting to evaluate if the pattern of immune response in
colitis model induced by DSS could be changed by treatment with
the methanolic extract of C. mexicana and this pattern can be eval-
uated by the type of Th1 and Th17 cytokines produced at the site
of injury.
Our ﬁndings showed that the levels of all cytokines analyzed,
including IFN-, IL-12, TNF- (Th1 pattern), IL-6, and IL-17A (Th17
pattern), were higher in the colon tissue of DSS-treated mice com-
pared with those not treated with DSS; however, these levels were
reduced by treatment with the methanolic extract obtained from
the green seaweed C. mexicana. These results indicate that the
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Fig. 3. Levels of Th1 and Th17 cytokines observed in cultured colonic tissue of mice with DSS-induced colitis treated with Caulerpa mexicana methanolic extract. Mice were
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egative control. The production of (A) IFN-, (B) IL-6, (C) IL-12, (D) IL-17A and (E) 
ean  ± SD (n = 5) *p < 0.05 in the vehicle-treated control group vs. the DSS-induced
ethanolic extract exerts an anti-inﬂammatory effect in UC by neg-
tively regulating the pro-inﬂammatory cytokine levels. Reduction
f the levels of these inﬂammatory mediators may  have occurred by
wo possible mechanisms. The ﬁrst is associated with the capacity
f the C. mexicana methanolic extract to directly inhibit cytokine
ecretion from innate immune cells, as previously demonstrated
Bitencourt et al., 2011), and the latter is related to the reduction of
ell migration to the colonic mucosa as an indirect mechanism to
ecrease cytokine levels.
Currently some studies have shown the efﬁcacy of nat-
ral products in the treatment of experimental IBD. These
tudies demonstrated that curcumin–piperine mixtures in self-
icroemulsifying (CUR-PIP-SMEDDS), ellargic acid, mangiferin and
lipein ameliorate the DSS-induced colitis in mice through the
eduction in DAI and histopathological lesion, and downregulat-
ng inﬂammatory mediators such as MPO  activity, IFN-, TNF-
nd IL-6 levels, COX-2 and iNOS expression and interfering with
he signaling pathways of p38 MAPK, NF-B, and STAT3 (Dou
t al., 2014; Li et al., 2015; Giner et al., 2011; Marín et al.,
013).exicana methanolic extract (2 mg/kg/day i.v.  up to 14 days); saline was used as a
 were determined as described in Material and Methods section. Values represent
 group; signiﬁcance between the treated groups was determined by ANOVA.
The green seaweed C. mexicana is composed of numerous
compounds endowed with potential biological activities (Carrillo-
Dominguez et al., 2002). Some of them could contribute to the
negative effects mediated by the methanolic extract on cytokine
secretion at the colonic mucosa and on inﬂammatory cell migra-
tion to the colon. In fact, compounds like caulerpin and other
puriﬁed indolic alkaloids from Caulerpa species such as Caulerpa
racemosa, have proven anti-inﬂammatory activity reducing cell
migration in peritonitis models (Bamias and Cominelli, 2007)
and sulphated polysaccharides isolated from C. mexicana has
anti-inﬂammatory and antinociception activity (Carneiro et al.,
2014).
Therefore, new studies are needed to isolate the compounds
from the extract and evaluate their mechanisms of action. Fur-
thermore, considering the great reduction in the clinical symptoms
and cytokine secretion, but only slight amelioration of histologi-
cal damage, it is possible that the association of the C. mexicana
methanolic extract with conventional therapies or new approaches
could also guarantee mucosal healing alongside improved clinical
symptoms.
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onclusions
In summary, our data show that the treatment of mice with
ethanolic extract of C. mexicana signiﬁcantly ameliorate the clin-
cal signs observed in UC and decrease the levels of cytokine from
h1 (IFN-g, IL-12 and TNF-a) and Th17 (IL-6 and IL-17) immune
esponse pattern and this decrease could be associated with reduc-
ion of tissue damage observed in the colon of the animals that
eceived DSS. Therefore this extract appears promising for research
n metabolites that may  be effective in the treatment of UC.
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